meclizine has been researched along with Reperfusion Injury in 2 studies
Meclizine: A histamine H1 antagonist used in the treatment of motion sickness, vertigo, and nausea during pregnancy and radiation sickness.
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rongen, GA | 1 |
| Kishi, S | 1 |
| Campanholle, G | 1 |
| Gohil, VM | 1 |
| Perocchi, F | 1 |
| Brooks, CR | 1 |
| Morizane, R | 1 |
| Sabbisetti, V | 1 |
| Ichimura, T | 1 |
| Mootha, VK | 1 |
| Bonventre, JV | 1 |
2 other studies available for meclizine and Reperfusion Injury
| Article | Year |
|---|---|
High Dose Meclizine Prevents Renal Ischemia-Reperfusion Injury in Healthy Male Mice.
Topics: Acute Kidney Injury; Animals; Kidney; Male; Meclizine; Mice; Reperfusion Injury | 2015 |
Meclizine Preconditioning Protects the Kidney Against Ischemia-Reperfusion Injury.
Topics: Acute Kidney Injury; Adenosine Triphosphate; Animals; Cell Respiration; Cytochromes c; Deoxyglucose; | 2015 |